{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:26Z","timestamp":1791925706108,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"publisher","award":["PE00000006 CUP H93C22000660006"],"award-info":[{"award-number":["PE00000006 CUP H93C22000660006"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cbi.2023.110839","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T02:43:42Z","timestamp":1703213022000},"page":"110839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Signature of paraoxonases in the altered redox homeostasis in Alzheimer's disease"],"prefix":"10.1016","volume":"388","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8826-7556","authenticated-orcid":false,"given":"Sarah","family":"Beggiato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-0560","authenticated-orcid":false,"given":"Francesca","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-6178","authenticated-orcid":false,"given":"Arianna","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Trentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Valacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cervellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-6414","authenticated-orcid":false,"given":"Luca","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cbi.2023.110839_bib1","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.cbi.2023.110839_bib2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2010.02.016","article-title":"Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease","volume":"48","author":"Bradley","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.cbi.2023.110839_bib3","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.freeradbiomed.2008.03.012","article-title":"Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease","volume":"44","author":"Resende","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2023.110839_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101049","article-title":"Brain lipid peroxidation and Alzheimer disease: synergy between the butterfield and Mattson laboratories","volume":"64","author":"Butterfield","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.cbi.2023.110839_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12040856","article-title":"The 4-hydroxynonenal-protein adducts and their biological relevance: are some proteins preferred targets?","volume":"12","author":"Milkovic","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2023.110839_bib6","article-title":"Oxidative stress and 4-hydroxy-2-nonenal (4-Hne): implications in the pathogenesis and treatment of aging-related diseases","volume":"2022","author":"Li","year":"2022","journal-title":"J. Immunol. Res."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2023.110839_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/00207459408986291","article-title":"Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls","volume":"75","author":"Chen","year":"1994","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.cbi.2023.110839_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/exnr.1997.6750","article-title":"Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease","volume":"150","author":"Marcus","year":"1998","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.cbi.2023.110839_bib9","doi-asserted-by":"crossref","first-page":"e2499","DOI":"10.1038\/cddis.2016.389","article-title":"Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2\/are pathway in Alzheimer's disease models","volume":"7","author":"Lipton","year":"2016","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cbi.2023.110839_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10030339","article-title":"Paraoxonase-1 and -3 protein expression in the brain of the Tg2576 mouse model of Alzheimer's disease","volume":"10","author":"Salazar","year":"2021","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.cbi.2023.110839_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.23736\/S0026-4806.18.05875-5","article-title":"Evaluating the link between paraoxonase-1 levels and Alzheimer's disease development","volume":"110","author":"Cervellati","year":"2019","journal-title":"Minerva Med."},{"issue":"5","key":"10.1016\/j.cbi.2023.110839_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8050118","article-title":"Paraoxonases activities and polymorphisms in elderly and old-age diseases: an overview","volume":"8","author":"Levy","year":"2019","journal-title":"Antioxidants"},{"issue":"1\u20132","key":"10.1016\/j.cbi.2023.110839_bib13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.cbi.2023.110839_bib14","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1172\/JCI57671","article-title":"Pon-dering differences in Hdl function in coronary artery disease","volume":"121","author":"Mineo","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.cbi.2023.110839_bib15","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1074\/jbc.M512595200","article-title":"The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (Pon1) is essential for Pon1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux","volume":"281","author":"Rosenblat","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.cbi.2023.110839_bib16","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/CIRCULATIONAHA.106.681700","article-title":"Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation","volume":"115","author":"Horke","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cbi.2023.110839_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/nrc.20008","article-title":"Paraoxonase 2 (Pon2) polymorphisms and Parkinson's disease","volume":"34","author":"Costa","year":"2004","journal-title":"Neurosci. Res. Commun."},{"key":"10.1016\/j.cbi.2023.110839_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuro.2013.08.011","article-title":"Paraoxonase-2 (Pon2) in brain and its potential role in neuroprotection","volume":"43","author":"Costa","year":"2014","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.cbi.2023.110839_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jnc.13240","article-title":"Serum paraoxonase and arylesterase activities of paraoxonase-1 (Pon-1), mild cognitive impairment, and 2-year conversion to dementia: a pilot study","volume":"135","author":"Cervellati","year":"2015","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.cbi.2023.110839_bib20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3233\/JAD-210137","article-title":"Paraoxonase 1, B vitamins supplementation, and mild cognitive impairment","volume":"81","author":"Perla-Kajan","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cbi.2023.110839_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.890855","article-title":"Effects of ultramicronized palmitoylethanolamide on mitochondrial bioenergetics, cerebral metabolism, and glutamatergic transmission: an integrated approach in a triple transgenic mouse model of Alzheimer's disease","volume":"14","author":"Bellanti","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.cbi.2023.110839_bib22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cbi.2023.110839_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101481","article-title":"Additive effect of combined pollutants to Uv induced skin oxinflammation damage. Evaluating the protective topical application of a cosmeceutical mixture formulation","volume":"34","author":"Ferrara","year":"2020","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.cbi.2023.110839_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8080287","article-title":"Crosstalk between adipokines and paraoxonase 1: a new potential Axis linking oxidative stress and inflammation","volume":"8","author":"Tisato","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2023.110839_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2010.06.011","article-title":"Characterization of the 3xtg-ad mouse model of Alzheimer's disease: Part 2. Behavioral and cognitive changes","volume":"1348","author":"Sterniczuk","year":"2010","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.cbi.2023.110839_bib26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/iub.347","article-title":"Human tissue distribution of paraoxonases 1 and 2 Mrna","volume":"62","author":"Mackness","year":"2010","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.cbi.2023.110839_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.taap.2011.02.014","article-title":"Paraoxonase 2 (Pon2) in the mouse central nervous system: a neuroprotective role?","volume":"256","author":"Giordano","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2023.110839_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-60761-350-3_8","article-title":"Temporal and tissue-specific patterns of Pon3 expression in mouse: in situ hybridization analysis","volume":"660","author":"Shih","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.cbi.2023.110839_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.freeradbiomed.2008.03.023","article-title":"Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues","volume":"45","author":"Marsillach","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.cbi.2023.110839_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9121224","article-title":"Hdl proteome and Alzheimer's disease: evidence of a link","volume":"9","author":"Marsillach","year":"2020","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.cbi.2023.110839_bib31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2004.02373.x","article-title":"Uptake and transport of high-density lipoprotein (Hdl) and Hdl-associated alpha-tocopherol by an in vitro blood-brain barrier model","volume":"89","author":"Balazs","year":"2004","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.cbi.2023.110839_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9050456","article-title":"Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia","volume":"9","author":"Romani","year":"2020","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.cbi.2023.110839_bib33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","article-title":"Human paraoxonases (Pon1, Pon2, and Pon3) are lactonases with overlapping and distinct substrate specificities","volume":"46","author":"Draganov","year":"2005","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.cbi.2023.110839_bib34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1080\/5760310001621351-1","article-title":"Oxidative inactivation of Paraoxonase1, an antioxidant protein and its effect on antioxidant action","volume":"37","author":"Nguyen","year":"2003","journal-title":"Free Radic. Res."},{"issue":"3","key":"10.1016\/j.cbi.2023.110839_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/labinvest.2016.148","article-title":"Proof of the quantitative potential of immunofluorescence by mass spectrometry","volume":"97","author":"Toki","year":"2017","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.cbi.2023.110839_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030747","article-title":"Spatial and temporal protein modules signatures associated with Alzheimer disease in 3xtg-ad mice are restored by early ubiquinol supplementation","volume":"12","author":"Llanos-Gonzalez","year":"2023","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.cbi.2023.110839_bib37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.tics.2015.07.008","article-title":"Adolescence as a sensitive period of brain development","volume":"19","author":"Fuhrmann","year":"2015","journal-title":"Trends Cognit. Sci."},{"issue":"4","key":"10.1016\/j.cbi.2023.110839_bib38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbadis.2006.10.014","article-title":"Alzheimer disease, the two-hit hypothesis: an update","volume":"1772","author":"Zhu","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"24","key":"10.1016\/j.cbi.2023.110839_bib39","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1021\/acschemneuro.0c00637","article-title":"Apolipoprotein J in Alzheimer's disease: shedding light on its role with cell signaling pathway perspective and possible therapeutic approaches","volume":"11","author":"Moezzi","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.cbi.2023.110839_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11060984","article-title":"Association between serum concentrations of apolipoprotein a-I (Apoa-I) and Alzheimer's disease: systematic review and meta-analysis","volume":"11","author":"Zuin","year":"2021","journal-title":"Diagnostics"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723005069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723005069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:52:01Z","timestamp":1736365921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723005069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"alternative-id":["S0009279723005069"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110839","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signature of paraoxonases in the altered redox homeostasis in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110839"}}